Key result
Admission NT-proBNP predicts unfavorable 90-day functional outcomes in ischemic stroke, though NIHSS offers superior accuracy.
Why the study?
Does admission NT-proBNP predict stroke severity and 90-day functional outcome in patients with acute ischaemic stroke?
Population
90 consecutive patients with Acute Ischaemic Stroke, mean age 61.3±12.5 years, 65.6% male, from a single…
Design
Cohort
Follow-up
90 days
Authors
Loading...
May aid acute ischaemic stroke prognostication; hypothesis-generating and requires prospective validation before clinical use.
Cohort (n=90)
No
Does admission NT-proBNP predict stroke severity and 90-day functional outcome in patients with acute ischaemic stroke?
Effect estimate: OR 1.00 (95% CI 1.00-1.01)
p-value: p=0.049
Admission NT-proBNP is significantly associated with stroke severity and 90-day functional outcomes in acute ischaemic stroke, serving as a potential adjunct biomarker for prognostication.
Vallisree et al. (2026) conducted a cohort in Acute Ischaemic Stroke (n=90). Admission NT-proBNP was evaluated on Unfavourable functional outcome at 90 days (OR 1.00, 95% CI 1.00-1.01, p=0.049). Admission NT-proBNP was an independent predictor of unfavourable 90-day functional outcome in acute ischaemic stroke (OR 1.00; 95% CI 1.00-1.01; p=0.049), though NIHSS had superior accuracy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: